Skip to main content
Lalitha Nayak, MD, Oncology, Cleveland, OH, UH Cleveland Medical Center

LalithaNayakMD

Oncology Cleveland, OH

Hematologic Oncology

Instructor, Medicine, Case Western Reserve University School of Medicine

Dr. Nayak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nayak's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Hematology and Oncology
    Cleveland, OH 44106
    Phone+1 216-844-3951
    Fax+1 216-844-5759
  • Is this information wrong?

Summary

  • Dr. Lalitha Nayak is an oncologist in Cleveland, OH and is affiliated with University Hospitals Cleveland Medical Center. She received her medical degree from Goa Medical College and has been in practice 23 years. She specializes in hematologic oncology and is experienced in thrombotic disorders, bleeding disorders, and general / benign hematology.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Allegheny Health Network Medical Education Consortium (AGH)
    Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2001 - 2003
  • Goa Medical College
    Goa Medical CollegeClass of 1994

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2008 - 2026
  • PA State Medical License
    PA State Medical License 2001 - 2010
  • KY State Medical License
    KY State Medical License 2007 - 2008
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Assessment of Bleeding Phenotype in Hemophilia _ By a Novel Point-of-Care Global Assay
    Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Venous Thromboembolism (VTE) in Sickle Cell Disease (SCD) Is Associated with Neutrophilia
    Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura
    Lalitha V. Nayak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Laboratory & Translational Hematology 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Friday Scientific Workshop on the Interplay Between Coagulation and Malignancy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hepatocyte-Derived Tissue Plasminogen Activator Regulates Systemic Fibrinolysis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • The Research Could Lead to Safer Ways to Treat Patients with Blood Clots
    The Research Could Lead to Safer Ways to Treat Patients with Blood ClotsOctober 2nd, 2022
  • Cancer Drug Boosts Levels of Vascular-Protective Gene, KLF2
    Cancer Drug Boosts Levels of Vascular-Protective Gene, KLF2June 12th, 2014

Hospital Affiliations